Transitioning to Denosumab from Continuous Alendronate Therapy Further Improves BMD in Postmenopausal Women with Osteoporosis

Article Information

DOI 
http://dx.doi.org/10.1177/155989771105009
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2011 MD Conference Express

Author Information

  1. Rita Buckley
  1. Henry G. Bone, MD
    1. Michigan Bone and Mineral Clinic, Grosse Pointe, Michigan, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015100
Jun 2015100
Jul 2015311
Aug 2015200
Oct 2015432
Nov 2015010
Total1753

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Transitioning to Denosumab from Continuous Alendronate Therapy Further Improves BMD in Postmenopausal Women with Osteoporosis
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Diabetes & Endocrinology Clinical Trials
Metabolic Bone Disease
Menopause